NEW YORK (GenomeWeb News) – Myriad Genetics reported after the close of the market Tuesday that its fourth quarter revenues climbed 31 percent year over year partially driven by a 19 percent increase in revenue for its flagship BRACAnalysis test.

The Salt Lake City-based molecular diagnostics firm brought in total revenues of $174.1 million for the three months ended June 30, compared to revenues of $133 million for the fourth quarter of 2012. It beat the consensus Wall Street estimate for revenues of $159.9 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

In Nature this week: ash dieback disease fungal genome, and more.

May
15
Sponsored by
Tecan

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.

Jun
20
Sponsored by
PerkinElmer

In this webinar, Michael Quail of the R&D Sequencing team at the Wellcome Trust Sanger Institute will provide an expert perspective on library prep for next-generation sequencing.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.